Criticalads/draft_first_ads.txt · CV-NC-12
“Struggling with insomnia?”
→ “Supports restful sleep”
Names insomnia, a recognized sleep disorder, as the product's target. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.
Criticalother/draft_amazon_listing.txt · CV-NC-12
“Natural Sleep Aid for Insomnia Relief”
→ “Supports restful sleep”
Names insomnia, a recognised sleep disorder, and claims relief. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.
Criticalother/draft_amazon_listing.txt · CV-PP-08
“Insomnia Relief”
→ Remove disease terms from title, bullets, A+ content, and backend keywords.
A disease term in the Amazon title can trigger automated suppression. Can lead to: FDA: a warning letter treating it as a drug claim, Amazon: listing suppression.
Criticalother/draft_amazon_listing.txt · CV-DV-01
“cures restless nights”
→ Remove.
'Cures' is an explicit disease verb. It can get the product treated as an unapproved drug. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.
Criticalother/draft_amazon_listing.txt · CV-NC-01
“Reduces anxiety and stress hormones”
→ “Promotes a sense of calm”
Anxiety is a recognised disease. Naming it creates a drug claim. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.
Criticalother/draft_amazon_listing.txt · CV-FR-07
“zero side effects”
→ Remove the claim.
Unsubstantiable safety absolute. Can lead to: FTC: a demand for the evidence behind a safety claim.
“Struggling with insomnia?”
→ “Formulated to support restful sleep.”
Meta prohibits ad copy implying knowledge of a user's personal health status. Can lead to: Meta: ad rejection.
“just pay shipping”
→ “$4.95 shipping today. Your first full bottle ships in 30 days at $59, and every 30 days after, until you cancel.”
Presents a paid enrollment as free without disclosing recurring charge terms. Can lead to: FTC: action under ROSCA, the negative-option law, Payment processor: an account review.
“Try Demo brand free - just pay shipping!”
→ “Trial ships today for $4.95, then $59 every 30 days until you cancel. Cancel online anytime.”
Trial offer with no disclosure of price, frequency, or cancellation terms. Can lead to: FTC: action under ROSCA, the negative-option law, Payment processor: an account review.
Highother/draft_amazon_listing.txt · CV-SB-03
“Fall asleep in 15 minutes”
→ Remove unless a trial supports the exact timeframe.
Time-to-result claim requires finished-product trial data. Can lead to: FTC: a demand for the substantiation, Competition Bureau: a misleading-advertising complaint, Ad Standards Canada: a complaint, Walmart: listing removal.
Highother/draft_amazon_listing.txt · CV-FR-04
“clinically proven herbal blend”
→ “Formulated with clinically studied ingredients”
'Proven' is an absolute the FTC does not accept without finished-product evidence. Can lead to: FTC: a demand for the substantiation, Competition Bureau: a misleading-advertising complaint, Ad Standards Canada: a complaint, Walmart: listing removal.
Highother/draft_amazon_listing.txt · CV-SB-01
“Doctor recommended”
→ Remove unless a documented survey exists.
Requires a defensible survey that is almost never held. Can lead to: FTC: a demand for the substantiation, Ad Standards Canada: a complaint, Walmart: listing removal.
Highother/draft_amazon_listing.txt · CV-FR-03
“FDA registered facility”
→ “Manufactured in an FDA-registered facility”
Needs precise facility framing. As written it implies regulatory endorsement. Can lead to: FDA: a misbranding charge for implying FDA approval, FTC: a demand for the substantiation.
Highother/draft_amazon_listing.txt · CV-ST-01
“Bullet 3: 100% natural, zero side effects, non-habit forming”
→ Add: 'This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'
Structure/function claims appear without the required FDA disclaimer. Can lead to: FDA: a misbranding charge for the missing disclaimer.
Mediumads/draft_first_ads.txt · CV-PR-04
“The sleep secret doctors won't tell you.”
→ “Supports restful sleep.”
Sensational health framing on Stripe's outrageous-claims prohibited list. Can lead to: FTC: a demand for the substantiation, Payment processor: an account review.
Mediumads/draft_first_ads.txt · CV-PR-06
“Limited stock - only 12 left!”
→ Remove untrue stock alerts.
Stock scarcity alert that is likely not true in real time is deceptive and prohibited. Can lead to: FTC: a finding of deceptive urgency, Payment processor: an account review.
Mediumother/draft_amazon_listing.txt · CV-SB-09
“100% natural”
→ Name the actual attribute: 'no artificial colors or sweeteners'.
'Natural' is challengeable by FTC where processing is involved. Can lead to: FTC: a demand for the substantiation.
Mediumother/draft_amazon_listing.txt · CV-SB-11
“non-habit forming”
→ Remove unless documented.
Safety claim requiring documented evidence. Can lead to: FTC: a demand for the evidence behind a safety claim.